Bela Denes
Chief Tech/Sci/R&D Officer chez LANTHEUS HOLDINGS, INC.
Profil
Bela S.
Denes is currently working as a Member at the American College of Surgeons and as a Vice President-Global Medical Affairs at Lantheus Holdings, Inc. In the past, he worked as a Lead-Global Medical Affairs at Amgen, Inc. and as a Chief Medical Officer & Vice President at Clarus Therapeutics, Inc.
Postes actifs de Bela Denes
| Sociétés | Poste | Début |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 07/04/2021 |
| American College of Surgeons | Corporate Officer/Principal | - |
Anciens postes connus de Bela Denes
| Sociétés | Poste | Fin |
|---|---|---|
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
Clarus Therapeutics, Inc.
 Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Clarus Therapeutics, Inc.
Clarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Clarus Therapeutics, Inc. operated as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy. It offered JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company was founded by Robert E. Dudley in February 2004 and was headquartered in Northbrook, IL. | Health Technology |
